The EP PerMed Fast Track Validation Programme has been established to address a critical bottleneck in the development of PM solutions: the validation phase. Personalised medicine is a highly innovative and technology-driven field that holds immense potential for improving patient outcomes and optimising healthcare delivery. However, transforming groundbreaking innovations into market-ready products requires rigorous validation to ensure they meet the needs and expectations of end-users, including clinicians and patients.
Validation is essential for achieving and maintaining product-market fit, a key determinant of commercial success. It involves a thorough assessment of whether a product or feature effectively addresses the identified needs and bottlenecks. This process is often conducted in specialised validation centres, which provide the necessary infrastructure and expertise to test and validate innovations. Despite the availability of numerous validation centres across Europe, many innovators struggle to identify and access these resources, hindering the progress of their projects.
Requirements
- Applications can be submitted by either a start-up or a team/researcher affiliated with an academic or healthcare research organization registered in an EU Member State or a Horizon Europe-associated country.
- Applications must be formulated in English.
- Applicants must submit their applications via the application platform before the deadline on 13 March 2025 at 16:00 CET.
Deadline: 13 March 2025.
Español
English